Discovery of selective aminothiazole aurora kinase inhibitors

被引:37
作者
Andersen, Carsten B. [2 ]
Wan, Yongqin [2 ]
Chang, Jae W. [1 ]
Riggs, Blake [4 ]
Lee, Christian [2 ]
Liu, Yi [2 ]
Sessa, Fabio [3 ]
Villa, Fabrizio [3 ]
Kwiatkowski, Nicholas [1 ]
Suzuki, Melissa [5 ]
Nallan, Laxman [2 ]
Heald, Rebecca [4 ]
Musacchio, Andrea [3 ]
Gray, Nathanael S. [1 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol,Dept Canc Biol, Boston, MA 02115 USA
[2] Novartis Res Fdn, Gen Inst, Dept Biol Chem, San Diego, CA 92121 USA
[3] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy
[4] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[5] Invitrogen Corp, Madison, WI 53558 USA
关键词
D O I
10.1021/cb700200w
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aurora family kinases regulate important events during mitosis including centrosome maturation and separation, mitotic spindle assembly, and chromosome segregation. Misregulation of Aurora kinases due to genetic amplification and protein overexpression results in aneuploidy and may contribute to tumorigenesis. Here we report the discovery of new small molecule aminothiazole inhibitors of Aurora kinases with exceptional kinase selectivity and report a 1.7 angstrom cocrystal structure with the Aurora B:INCENP complex from Xenopus laevis. The compounds recapitulate the hallmarks of Aurora kinase inhibition, including decreased histone H3 serine 10 phosphorylation, failure to complete cytokinesis, and endoreduplication.
引用
收藏
页码:180 / 192
页数:13
相关论文
共 48 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers [J].
Bischoff, JR ;
Anderson, L ;
Zhu, YF ;
Mossie, K ;
Ng, L ;
Souza, B ;
Schryver, B ;
Flanagan, P ;
Clairvoyant, F ;
Ginther, C ;
Chan, CSM ;
Novotny, M ;
Slamon, DJ ;
Plowman, GD .
EMBO JOURNAL, 1998, 17 (11) :3052-3065
[3]   Discovery and evaluation of N-cyclopropyl-2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5-ylmethyl)amino)benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2 [J].
Borzilleri, Robert M. ;
Bhide, Rajeev S. ;
Barrish, Joel C. ;
D'Arienzo, Celia J. ;
Derbin, George M. ;
Fargnoli, Joseph ;
Hunt, John T. ;
Jeyaseelan, Robert, Sr. ;
Kamath, Amrita ;
Kukral, Daniel W. ;
Marathe, Punit ;
Mortillo, Steve ;
Qian, Ligang ;
Tokarski, John S. ;
Wautlet, Barri S. ;
Zheng, Xiaoping ;
Lombardo, Louis J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (13) :3766-3769
[4]  
CHAN CSM, 1993, GENETICS, V135, P677
[5]   Crystal structure of aurora-2, an oncogenic serine/threonine kinase [J].
Cheetham, GMT ;
Knegtel, RMA ;
Coll, JT ;
Renwick, SB ;
Swenson, L ;
Weber, P ;
Lippke, JA ;
Austen, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (45) :42419-42422
[6]   Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores [J].
Ditchfield, C ;
Johnson, VL ;
Tighe, A ;
Ellston, R ;
Haworth, C ;
Johnson, T ;
Mortlock, A ;
Keen, N ;
Taylor, SS .
JOURNAL OF CELL BIOLOGY, 2003, 161 (02) :267-280
[7]   On the role of aurora-A in centrosome function [J].
Dutertre, S ;
Descamps, S ;
Prigent, C .
ONCOGENE, 2002, 21 (40) :6175-6183
[8]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132
[9]   A small molecule-kinase interaction map for clinical kinase inhibitors [J].
Fabian, MA ;
Biggs, WH ;
Treiber, DK ;
Atteridge, CE ;
Azimioara, MD ;
Benedetti, MG ;
Carter, TA ;
Ciceri, P ;
Edeen, PT ;
Floyd, M ;
Ford, JM ;
Galvin, M ;
Gerlach, JL ;
Grotzfeld, RM ;
Herrgard, S ;
Insko, DE ;
Insko, MA ;
Lai, AG ;
Lélias, JM ;
Mehta, SA ;
Milanov, ZV ;
Velasco, AM ;
Wodicka, LM ;
Patel, HK ;
Zarrinkar, PP ;
Lockhart, DJ .
NATURE BIOTECHNOLOGY, 2005, 23 (03) :329-336
[10]   Potent and selective aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition [J].
Fancelli, D ;
Berta, D ;
Bindi, S ;
Cameron, A ;
Cappella, P ;
Carpinelli, P ;
Catana, C ;
Forte, B ;
Giordano, P ;
Giorgini, ML ;
Mantegani, S ;
Marsiglio, A ;
Meroni, M ;
Moll, J ;
Pittalà, V ;
Roletto, F ;
Severino, D ;
Soncini, C ;
Storici, P ;
Tonani, R ;
Varasi, M ;
Vulpetti, A ;
Vianello, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (08) :3080-3084